JAG1 and Salla disease: Furthermore, both APEX1 knockdown and Jagged1 knockdown inhibited CD133+ GBC-SD cells proliferation, migration, invasion, and tumor growth, and promoted CD133+ GBC-SD cells apoptosis, demonstrating that APEX1 and Jagged1 possessed similar biological function in CD133+ GBC-SD cells.